Margaret Hahn

Margaret Hahn

University of Toronto

H-index: 35

North America-Canada

About Margaret Hahn

Margaret Hahn, With an exceptional h-index of 35 and a recent h-index of 30 (since 2020), a distinguished researcher at University of Toronto, specializes in the field of Schizophrenia, diabetes, insulin, obesity, cognition.

His recent articles reflect a diverse array of research interests and contributions to the field:

413. Identifying Predictors of Clozapine-Induced Weight Gain Through a Naturalistic Retrospective Chart Review

Neurocognitive correlates of metabolic dysregulation in individuals with mood disorders: a systematic review and meta-analysis

In vivo techniques for assessment of insulin sensitivity and glucose metabolism

Development of novel tools for dissection of central versus peripheral dopamine D2-like receptor signaling in dysglycemia

Olanzapine’s effects on hypothalamic transcriptomics and kinase activity

Evenamide: a potential pharmacotherapeutic alternative for treatment-resistant schizophrenia

Glucose dysregulation in antipsychotic-naive first-episode psychosis: in silico exploration of gene expression signatures

Healthcare providers’ perspectives on implementing a brief physical activity and diet intervention within a primary care smoking cessation program: a qualitative study

Margaret Hahn Information

University

Position

___

Citations(all)

4409

Citations(since 2020)

3608

Cited By

1732

hIndex(all)

35

hIndex(since 2020)

30

i10Index(all)

72

i10Index(since 2020)

66

Email

University Profile Page

Google Scholar

Margaret Hahn Skills & Research Interests

Schizophrenia

diabetes

insulin

obesity

cognition

Top articles of Margaret Hahn

413. Identifying Predictors of Clozapine-Induced Weight Gain Through a Naturalistic Retrospective Chart Review

Biological Psychiatry

2024/5/15

Neurocognitive correlates of metabolic dysregulation in individuals with mood disorders: a systematic review and meta-analysis

2024/3/7

In vivo techniques for assessment of insulin sensitivity and glucose metabolism

2024/3/1

Development of novel tools for dissection of central versus peripheral dopamine D2-like receptor signaling in dysglycemia

bioRxiv

2024/2/23

Olanzapine’s effects on hypothalamic transcriptomics and kinase activity

Psychoneuroendocrinology

2024/2/6

Evenamide: a potential pharmacotherapeutic alternative for treatment-resistant schizophrenia

International Journal of Neuropsychopharmacology

2024/2/1

Glucose dysregulation in antipsychotic-naive first-episode psychosis: in silico exploration of gene expression signatures

Translational Psychiatry

2024/1/10

Healthcare providers’ perspectives on implementing a brief physical activity and diet intervention within a primary care smoking cessation program: a qualitative study

BMC Primary Care

2024/1/6

Central insulin dysregulation in antipsychotic-naïve first-episode psychosis: In silico exploration of gene expression signatures

Psychiatry Research

2024/1/1

Depression in caregivers of patients with schizophrenia: a scoping review

2024/1

Clinical Improvement in Schizophrenia During Antipsychotic Treatment in Relation to Changes in Glucose Parameters: A Systematic Review

2023/9/7

Favourable cognitive changes observed with metabolic improvements in a patient with severe mental illness

Journal of Psychiatry and Neuroscience

2023/9/6

Margaret Hahn
Margaret Hahn

H-Index: 21

Pharmacological interventions for the prevention of antipsychotic-induced weight gain in people with schizophrenia: a Cochrane systematic review and meta-analysis

2024

Outcomes and clinical implications of intranasal insulin on cognition in humans: A systematic review and meta-analysis

2023/6/28

274. The Impact of Metabolic Dysregulation on Cognition in Mood Disorders: A Systematic Review and Meta-Analysis

2023/5/1

Emily Smith
Emily Smith

H-Index: 12

Margaret Hahn
Margaret Hahn

H-Index: 21

296. Dysglycemia and Clinical Improvement in Patients With Schizophrenia Treated With Antipsychotics: A Systematic Review

2023/5/1

498. Olanzapine Impairs Central Lipid-Mediated Regulation of Glucose Homeostasis

Biological Psychiatry

2023/5/1

145. Investigation of the Effects of Olanzapine on CNS Insulin-Mediated Brain Glucose Uptake Using 2DG Autoradiography

Biological Psychiatry

2023/5/1

13. Metabolomic Signatures Associated With Weight Gain and Psychosis Spectrum Diagnoses

Biological Psychiatry

2023/5/1

See List of Professors in Margaret Hahn University(University of Toronto)

Co-Authors

academic-engine